Table 1 |
||||
| Patient health outcomes | ||||
| Study group (N = 272) | Control group (N = 283) | P-value | ||
| Patient readmission rate (N, %) | 28 days | 11, 4.0% | 29, 10.2% | 0.005a |
| 84 days | 22, 8.1% | 55, 19.4% | <0.001a | |
| Readmission LOS | 28 days | 2.7 (1.4, 4.1) | 5.0 (2.6, 7.3) | 0.456b |
| (Mean, 95% CI) | 84 days | 4.5 (2.6, 6.4) | 6.0 (4.0, 8.0) | 0.607b |
| Utility | Baseline | 0.723 (0.707, 0.739) | 0.735 (0.719, 0.752) | 0.308c |
| (Mean, 95% CI) | 28 days | 0.764 (0.748, 0.781) | 0.727 (0.710, 0.744) | <0.001c |
| 84 days | 0.778 (0.762, 0.795) | 0.751 (0.734, 0.768) | 0.002c | |
| Within group comparison | <0.001d | 0.011 d | ||
| QALY gain from baseline | 28 days | 0.0016 (0.0010, 0.0022) | −0.0003 (−0.0009, 0.0003) | <0.001b |
| (Mean, 95% CI) | 84 days | 0.0089 (0.0060, 0.0117) | 0.0003 (−0.0024, 0.0030) | <0.001b |
a Pearson's chi-squared test,
b Mann–Whitney U-test,
c ANCOVA test (28 days and 84 days adjusted by baseline),
d Repeated measures ANOVA.
Wong et al. BMC Health Services Research 2012 12:479 doi:10.1186/1472-6963-12-479
